Публикации

2021 год

  1. Artem V. Eremeev, Olga S. Lebedeva, Margarita E. Bogomiakova, Maria A. Lagarkova, Alexandra N. Bogomazova, Cerebral Organoids — Challenges to Establish a Brain Prototype, 2021 Jul 15;10(7):1790. doi: 10.3390/cells10071790.
  2. M.E.Bogomiakova, E.K.Sekretova, A.V.Eremeev, L.D.Shuvalova, P.A.Bobrovsky, E.A.Zerkalenkov, O.S.Lebedeva, M.A.Lagarkova, Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing, Stem Cell Research 2021, vol. 55. doi: 10.1016/j.scr.2021.102451.
  3. Anton V. Turaev, Ekaterina A. Isaakovaa, Vjacheslav V. Severova, Alexandra N. Bogomazova, Timofei S. Zatsepin, Makar V. Sardushkin, Andrey V.Aralove, Maria A. Lagarkova, Galina E. Pozmogova, Anna M. Varizhuk, Genomic DNA i-motifs as fast sensors responsive to near-physiological pH microchanges, Biosensors and Bioelectronics 2021, vol. 175. doi: 10.1016/ j.bios.
  4. Victor Spangenberg, Marine Arakelyan, Eduard Galoyan, Irena Martirosyan, Alexandra Bogomazova, Elena Martynova, Marcelo de Bello Cioffi, Thomas Liehr, Ahmed Al-Rikabi, Fedor Osipov, Varos Petrosyan, Oxana Kolomiets, Meiotic synapsis of homeologous chromosomes and mismatch repair protein detection in the parthenogenetic rock lizard Darevskia unisexualis, Molecular Reproduction & Development 2021 2021 Feb;88(2):119-127. doi: 10.1002/mrd.23450.
  5. Ksenia Anufrieva, Victoria Shender, Polina Shnaider, Olga Ivanova, Veronika Boichenko, Zhanat Baymukhanova, Maria Lagarkova, Georgij Arapidi, Molecular mechanisms underlying synergistic anticancer effects of spliceosome inhibitor combined with cisplatin, The FASEB journal 2021, doi:10.1096/fasebj.2021.35.S1.05322.
  6. Shender V., Shnaider P., Anufrieva K., Ivanova O., Arapidi G., Malyants I., Baymukhanova Z., Pavlyukov M., Lagarkova M., Govorun V., Spliceosomal components-mediated intercellular communication: role in chemoresistance acquisition of ovarian cancer cells, FASEB Journal 2021, vol. 35, doi.org/10.3390/ijms21217872.

2020 год

  1. L D Shuvalova , A V Eremeev, A N Bogomazova, E V Novosadova, E A Zerkalenkova, Yu V Olshanskaya, E Y Fedotova, E S Glagoleva, S N Illarioshkin, O S Lebedev, M A Lagarkova, Generation of induced pluripotent stem cell line RCPCMi004-A derived from patient with Parkinson's disease with deletion of the exon 2 in PARK2 gene, Stem Cell Research and Therapy 2020, 44, 1-5, doi: 10.1016/j.scr.2020.101733.
  2. Aleksandra S Taran, Lilia D Shuvalova, Maria A Lagarkova, Irina B Alieva, Huntington's Disease-An Outlook on the Interplay of the HTT Protein, Microtubules and Actin Cytoskeletal Components, Cells 2020, 9, 1514, https://doi.org/10.3390/cells9061514.
  3. Volovikov E.A., Davidenko A.V., Lagarkova M.A., Molecular Mechanisms of Spinocerebellar Ataxia Type 1, Russian Journal of Genetics 2020, 56, 129-141, doi: 10.1007/s12311-008-0009-0.

2019 год

  1. Еремеев А.В., Воловиков Е.А., Шувалова Л.Д., Давиденко А.В., Хомякова Е.А., Богомякова М.Е., Лебедева О.С., Зубкова О.А., Лагарькова М.А. «Голь на выдумки хитра», или дешевый, надежный и воспроизводимый способ получения органоидов, Биохимия, 2019, Т. 84, № 3, с. 448 – 456. doi: 10.1134/S032097251903014X.
  2. Лагарькова М.А.Такие разные стволовые клетки, Биохимия, 2019, Т. 84, № 3, с. 293 – 296. doi: 10.1134/S0320972519030011.
  3. Рыбцов С.А., Лагарькова М.А. Развитие гемопоэтических стволовых клеток в раннем эмбрионе млекопитающих, , Биохимия, 2019, Т. 84, № 3, с. 297 – 313. doi: 10.1134/S0320972519030023.
  4. Богомякова М. Е., Еремеев А. В., Лагарькова М. А. "Свой среди чужих": можно ли создать гипоиммуногенные линии плюрипотентных стволовых клеток?", Молекулярная биология, 2019, Т. 53, № 5, с. 725–740. doi: 10.1134/S0026898419050045.

2018 год

  1. Лебедева О.С., Лагарькова М.А. Плюрипотентные стволовые клетки для моделирования и клеточной терапии болезни Паркинсона // Биохимия. 2018, том 83, вып. 9, с. 1318–1330. doi: 10.1134/S0320972518090063.
  2. Харитонов А.Е., Сурдина А.В., Лебедева О.С., Богомазова А.Н., Лагарькова М.А.
    Возможности использования плюрипотентных стволовых клеток для восстановления поврежденного пигментного эпителия сетчатки глаза // Acta Naturae. 2018. Том 10, № 3, с. 31–41. doi: 10.32607/20758251-2018-10-3-30-39.
  3. Vigont V., Nekrasov E., Shalygin A., Gusev K., Klushnikov S., Illarioshkin S., Kiselev S., Lagarkova M., Kaznacheyeva E. Patient-specific iPSCs-based model of Huntington’s disease allows the study of store-operated calcium channel drug targeting // Frontiers in Pharmacologу. 2018. Vol. 9: 696. doi: 10.3389/fphar.2018.00696.
  4. Panova, A. V., Bogomazova, A. N., Lagarkova, M. A., Kiselev, S. L. Epigenetic reprogramming by naïve conditions establishes an irreversible state of partial X chromosome reactivation in female stem cells Oncotarget, 2018, May 18, 9(38) 25136–25147 IF 5,0. doi: 10.18632/oncotarget.25353.
  5. Anufrieva K.S.., Shender V.O., Arapidi G.P., Pavlyukov M.S., Shakhparonov M.I., Shnaider P.V., Butenko I.O., Lagarkova M.A., Govorun V.M. Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells // Genome Medicine, 2018. Vol. 10: 49. doi: 10.1186/s13073-018-0557-y.
  6. Sultanov R., Lebedeva O., Arapidi G., Lagarkova M., Kiselev S. Methylation profile of induced pluripotent stem cells generated by integration and integration-free approaches // Data Brief. 2018. Vol. 17:662-666. doi: 10.1016/j.dib.2018.01.061.
  7. A. E. Kharitonov, A. V. Surdina, O. S. Lebedeva, A. N. Bogomazova, M. A. Lagarkova. Possibilities for Using Pluripotent Stem Cells for Restoring Damaged Eye Retinal Pigment Epithelium ACTA NATURAE, 2018, Vol. 10 № 3 (38) С. 30-39 IF 2,2 https://doi.org/10.32607/20758251-2018-10-3-30-39.
  8. Lebedeva O.S. Lagarkova M.A. Pluripotent Stem Cells for Modelling and Cell Therapy of Parkinson’s Disease Biochemistry (Moscow), 2018, 83(9):1046-1056 IF 1,7 doi: 10.1134/S0006297918090067.

2017 год

  1. Prokofjeva M., Tsvetkov VB., Basmanov D., Varizhuk AM., Lagarkova MA., Smirnov IP., Prusakov K., Klinov DV., Prassolov V., Pozmogova GE, Mikhailov SN., Anti-HIV Activities of Intramolecular G4 and Non-G4 Oligonucleotides // Nucleic acid therapeutics. 2017. Vol. 27: 56-66 doi: 10.1089/nat.2016.0624.
  2. Philonenko E. S., Shutova M. V., Khomyakova E. A., Vassina E.M., Lebedeva O.S., Kiselev S.L., Lagarkova M. A. Differentiation of Human Pluripotent Stem Cells into Mesodermal and Ectodermal Derivatives Is Independent of the Type of Isogenic Reprogrammed Somatic Cells, Acta Naturae. – 2017. – V. 9. - №1. – P. 68-74. doi:10.32607/20758251-2017-9-1-68-74.